Keyphrases
Mantle Cell Lymphoma
100%
Prognostic Biomarker
100%
International Prognostic Index
100%
β2-microglobulin (β2-MG)
100%
Confidence Interval
37%
Overall Survival
37%
Prognostic Factors
25%
Hazard Ratio
25%
Medical Center
12%
Rituximab
12%
Multivariate Analysis
12%
Advanced Stage
12%
Asan
12%
Follow-up Interval
12%
Prognostic Score
12%
Median Overall Survival
12%
Seoul
12%
Mantle Cell Lymphoma International Prognostic Index
12%
Medicine and Dentistry
Biological Marker
100%
Mantle Cell Lymphoma
100%
Beta 2 Microglobulin
100%
Mantle Cell Lymphoma International Prognostic Index
100%
Overall Survival
44%
Prognostic Factor
22%
Hazard Ratio
22%
Biological Product
11%
Rituximab
11%
Multivariate Analysis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Beta 2 Microglobulin
100%
Mantle Cell Lymphoma
100%
Overall Survival
50%
Biological Product
12%
Rituximab
12%
Immunology and Microbiology
Lymphoma Cell
100%
Beta-2 Microglobulin
100%
Prognostic Biomarker
100%
Overall Survival
50%
Rituximab
12%
Biological Product
12%
Biochemistry, Genetics and Molecular Biology
Beta-2 Microglobulin
100%
Overall Survival
50%
Multivariate Analysis
12%
Rituximab
12%